Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery

Not Applicable

• Conditions: Dry Eye
• Interventions: Drug: Omega 3

• Registration Number: NCT04411615
• Lead Sponsor: Samsung Medical Center

Brief Summary

To evaluate the clinical outcomes of the systemic re-esterified triglyceride (rTG) form of omega-3 fatty acids in patients with dry eye symptoms after cataract surgery

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-05
• Study First Submitted: 2020-05-28
• Study First Submitted QC: 2020-06-01
• Last Update Submitted: 2020-06-01
• Study First Posted: 2020-06-02
• Last Update Posted: 2020-06-02
• Study Start: 2020-07-01
• Primary Completion: 2020-08-01
• Study Completion: 2021-02-28

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Non complicated cataract surgery
• Patients with dry eye symptom

Exclusion Criteria

• Using steroid eyedops,
• Using antibiotics eyedrops
• Surgery other than Cataract surgery
• Contact lens wearer
• Other systemic disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Omega	Omega 3	Omega-3 re-esterified triglyceride form

Primary Outcome Measures

Name	Time	Method
Dry eye symptom	1 month	Improvement of symptom